Intellectual Property India Publishes Patent Application for 'Thymic Cell Compositions And Methods Of Making' Filed by Thymmune Therapeutics, Inc.

MUMBAI, India, Nov. 21 -- Intellectual Property India has published a patent application (202517099050 A) filed by Thymmune Therapeutics, Inc., Cambridge, U.S.A., on Oct. 14, for 'thymic cell compositions and methods of making.'

Inventor(s) include Lim, Bing; Wang, Stan; Gerami-Naini, Behzad; Du, Qiumei; Beaman, Jr., Henry Thomas; and Schwarz, Benjamin A.

The application for the patent was published on Nov. 21, under issue no. 47/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure provides thymic cells, thymic organoids, and animal models comprising such thymic cells and thymic organoids. It also provides methods for inducing differentiation of pluripotent stem cells into definitive endoderm (DE), anterior foregut endoderm (AFE), ventral pharyngeal endoderm (VPE), thymic epithelial progenitor (TEP) cells, thymic epithelial cells (TECs) and thymic organoids in vitro and in vivo."

The patent application was internationally filed on Apr. 04, 2024, under International application No.PCT/US2024/023120.

Disclaimer: Curated by HT Syndication.